Unlock instant, AI-driven research and patent intelligence for your innovation.
Methods of using ZSCAN4 for rejuvenating human cells
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A cell, object technology applied in the field of rejuvenation of human cells using ZSCAN4
Inactive Publication Date: 2016-01-13
ELIXIRGEN
View PDF28 Cites 5 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although it has been shown that the human genome also contains the ZSCAN4 gene, Falco et al., DevBiol 307:539-550, 2007; Zalzman et al., Nature 464:858-863, 2010; PCT Publication Nos. WO2008 / 118957, WO2011 / 02880, WO2012 / 103235, None of WO2012 / 129342, WO2012 / 158561, and WO2012158564; or U.S. Patent Application Publication Nos. US2010 / 0105043, US2012 / 0129161, and US2012 / 0156305 provided experiments showing that Zscan4 expression in human cells resulted in the same effects as in murine embryonic cells support
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0368] Example 1: Zscan4 Expression Corrects Chromosomal Abnormalities in Mouse Embryonic Stem Cells
[0369] This example describes the discovery that expression of Zscan4, either by synthetic mRNA encoding Zscan4 or by a Sendai virus vector expressing Zscan4, can correct chromosomal abnormalities in mouse embryonic stem (ES). This example also demonstrates that synthetic mRNA encoding Zscan4 and Sendai virus vectors expressing Zscan4 can be used as biologics.
[0372]The MC1ZE murine ES cell line was previously reported (Amano et al., Nat Commun, 2013; 4:1966). MC1ZE cells were used as typical murine ES cells, which showed poor karyotype (ie, only about 20% of cells carried euploidy) due to long-term culture (passage number 33), and integration of exogenous genes. Cells were cultured at 37°C in 5% CO2 in complete ES medium as previously described (Amano et al., NatCommun, 2013; 4:1966.): DMEM (Gibco), 15% FBS (Atlanta...
Embodiment 2
[0389] Example 2: Effect of Zscan4 biological products on mouse embryonic stem cells
[0390] It has previously been shown that forced expression of exogenous murine Zscan4c from a plasmid vector integrated into the murine genome induces the expression of a unique set of genes including Tmem92, Stra8 and the endogenous Zscan4 gene (Amano et al., NatCommun, 2013; 4: 1966).
[0391] This example demonstrates that a Zscan4 biologic (eg, expressing Zscan4, either by a synthetic mRNA encoding Zscan4 or by a Sendai virus vector expressing Zscan4) exerts the same function in murine embryonic stem (ES) cells.
[0394]The MC1 murine embryonic stem (ES) cell line was previously used as a typical murine pluripotent stem cell to demonstrate the function of the exogenously introduced Zscan4c gene, which is integrated into the murine genome (Amano et al., NatCommun, 2013; 4:1966.) . MC1 cells were cultured at 37°C in 5% CO2 in compl...
[0406] The genes SERPINB4, DNMT3L, and DUX4 were identified as marker genes that were upregulated when the murine Zscan4c or human ZSCAN4 genes were overexpressed by a transgene-based gene expressionsystem.
[0407] This example demonstrates that Zscan4 biologics (e.g., expressing Zscan4—either by synthetic mRNA encoding Zscan4 or by a Sendai virus vector expressing Zscan4) can be produced in a manner similar to that of the transgene-based Zscan4 overexpression system used in murine pluripotent stem cells. way to act on human iPS cells. This example also demonstrates that synthetic mRNA encoding human ZSCAN4 and Sendai virus vectors expressing human ZSCAN4 can be used as therapeutic biologics for the treatment of human pluripotent stem cells.
[0410] Human foreskin fibroblasts were cultured on mitotically inactivated murin...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Property
Measurement
Unit
diameter
aaaaa
aaaaa
diameter
aaaaa
aaaaa
diameter
aaaaa
aaaaa
Login to View More
Abstract
The present disclosure relates to methods for increasing telomere length in one or more human cells and / or increasing genome stability of one or more human cells, for example by contacting one or more human cells with an agent that increases expression of Zscan4 in the one or more human cells. Methods of treating a subject in need of telomere lengthening, treating a disease or condition associated with a genomic and / or chromosomeabnormality, of rejuvenating one or more human cells, of rejuvenating tissues or organs, and of rejuvenating a subject in need thereof, for example by contacting one or more human cells in the subject with an agent that increases expression of Zscan4, or by administering to a subject in need thereof, an agent that increases expression of Zscan4 are also provided.
Description
[0001] Cross References to Related Applications [0002] This application claims the benefit of US Provisional Application No. 61 / 800,668, filed March 15, 2013, which is incorporated herein by reference in its entirety. [0003] Submit a sequence listing on an ASCIItext file [0004] The following submission on ASCIItext file is hereby incorporated by reference in its entirety: Sequence Listing in Computer Readable Form (CRF) (File Name: 699442000840SEQLIST.TXT, Date of Record: March 11, 2014, Size: 104KB) . technical field [0005] The present disclosure relates to methods of increasing telomere length and / or increasing genomic stability of one or more human cells in one or more human cells, for example, by combining one or more human cells with The one or more human cells are contacted with an agent that increases expression of Zscan4. The present disclosure further provides methods of treating a subject in need of telomere lengthening, methods of treating a disease or ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.